{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T16:55:06Z","timestamp":1780505706417,"version":"3.54.1"},"reference-count":109,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T00:00:00Z","timestamp":1656547200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007732","name":"American Macular Degeneration Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007732","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018133","name":"VitreoRetinal Surgery Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018133","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ophthalmologyscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Science"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.xops.2022.100192","type":"journal-article","created":{"date-parts":[[2022,7,5]],"date-time":"2022-07-05T12:25:21Z","timestamp":1657023921000},"page":"100192","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Neuroprotection for Age-Related Macular Degeneration"],"prefix":"10.1016","volume":"2","author":[{"given":"Jonathan B.","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan W.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Demetrios G.","family":"Vavvas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xops.2022.100192_bib1","doi-asserted-by":"crossref","DOI":"10.1038\/npjamd.2016.3","article-title":"A\u00a0glimpse at the aging eye","volume":"2","author":"Lin","year":"2016","journal-title":"NPJ Aging Mech Dis"},{"key":"10.1016\/j.xops.2022.100192_bib2","first-page":"2890","article-title":"Complement inhibition for geographic atrophy: a tempting target with mixed results","volume":"10","author":"Lin","year":"2021","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.xops.2022.100192_bib3","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1001\/archopht.119.10.1417","article-title":"A\u00a0randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8","volume":"119","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.xops.2022.100192_bib4","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/j.ophtha.2013.01.021","article-title":"Long-term effects of vitamins C and E, \u03b2-carotene, and zinc on age-related macular degeneration: AREDS report no. 35","volume":"120","author":"Chew","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2022.100192_bib5","doi-asserted-by":"crossref","first-page":"E696","DOI":"10.1073\/pnas.1718059115","article-title":"CFH and ARMS2 genetic risk determines progression to neovascular age-related macular degeneration after antioxidant and zinc supplementation","volume":"115","author":"Vavvas","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.xops.2022.100192_bib6","doi-asserted-by":"crossref","first-page":"E5640","DOI":"10.1073\/pnas.1804781115","article-title":"Reply to Vickers: Pharmacogenetics and progression to neovascular age-related macular degeneration-Evidence supporting practice change","volume":"115","author":"Vavvas","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.xops.2022.100192_bib7","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1001\/jama.2013.4997","article-title":"Lutein\u00a0+ zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial","volume":"309","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.xops.2022.100192_bib8","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.2147\/OPTH.S115900","article-title":"Tolerability in the elderly population of high-dose alpha lipoic acid: a potential antioxidant therapy for the eye","volume":"10","author":"Sarezky","year":"2016","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.xops.2022.100192_bib9","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.oret.2020.03.019","article-title":"Orally administered alpha lipoic acid as a treatment for geographic atrophy: a randomized clinical trial","volume":"4","author":"Kim","year":"2020","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.xops.2022.100192_bib10","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1001\/jamaophthalmol.2020.4409","article-title":"Effect of vitamin D and \u03c9-3 fatty acid supplementation on risk of age-related macular degeneration: an ancillary study of the VITAL Randomized Clinical Trial","volume":"138","author":"Christen","year":"2020","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.xops.2022.100192_bib11","doi-asserted-by":"crossref","first-page":"6131","DOI":"10.1167\/iovs.10-5637","article-title":"Treatment of geographic atrophy by the topical administration of OT-551: results of a phase II clinical trial","volume":"51","author":"Wong","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2022.100192_bib12","article-title":"Topical OT-551 for treating geographic atrophy: phase II results","volume":"51","author":"Sternberg","year":"2010","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2022.100192_bib13","article-title":"Elamipretide, a mitochondria-targeted drug, for the treatment of vision loss in dry AMD with noncentral geographic atrophy: results of the Phase 1 ReCLAIM Study","volume":"60","author":"Cousins","year":"2019","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2022.100192_bib14","article-title":"Phase 1 Clinical trial of elamipretide in intermediate age-related macular degeneration and high-risk drusen: ReCLAIM HRD Study","author":"Allingham","year":"2021","journal-title":"Ophthalmol Sci"},{"key":"10.1016\/j.xops.2022.100192_bib15","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3928\/23258160-20210528-05","article-title":"Safety and efficacy of intravitreal risuteganib for non-exudative AMD: a multicenter, Phase 2a, randomized, clinical trial","volume":"52","author":"Boyer","year":"2021","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"10.1016\/j.xops.2022.100192_bib16","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/IAE.0b013e318265801d","article-title":"Investigation of oral fenretinide for treatment of geographic atrophy in age-related macular degeneration","volume":"33","author":"Mata","year":"2013","journal-title":"Retina"},{"key":"10.1016\/j.xops.2022.100192_bib17","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1001\/archopht.116.6.759","article-title":"Effects of fenretinide (4-HPR) on dark adaptation","volume":"116","author":"Caruso","year":"1998","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.xops.2022.100192_bib18","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1097\/IAE.0000000000000606","article-title":"Phase ii, randomized, placebo-controlled, 90-day study of emixustat hydrochloride in geographic atrophy associated with dry age-related macular degeneration","volume":"35","author":"Dugel","year":"2015","journal-title":"Retina"},{"key":"10.1016\/j.xops.2022.100192_bib19","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1016\/j.ophtha.2018.03.059","article-title":"Emixustat hydrochloride for geographic atrophy secondary to age-related macular degeneration: a randomized clinical trial","volume":"125","author":"Rosenfeld","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2022.100192_bib20","first-page":"CD013154","article-title":"Visual cycle modulators versus placebo or observation for the prevention and treatment of geographic atrophy due to age-related macular degeneration","volume":"12","author":"Yeong","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.xops.2022.100192_bib21","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.oret.2018.03.001","article-title":"A\u00a0randomized phase 2 study of an anti-amyloid \u03b2 monoclonal antibody in geographic atrophy secondary to age-related macular degeneration","volume":"2","author":"Rosenfeld","year":"2018","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.xops.2022.100192_bib22","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/ng.3448","article-title":"A\u00a0large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants","volume":"48","author":"Fritsche","year":"2016","journal-title":"Nat Genet"},{"key":"10.1016\/j.xops.2022.100192_bib23","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ajo.2021.06.017","article-title":"Phase 1 study of the Anti-HtrA1 antibody-binding fragment FHTR2163 in geographic atrophy secondary to age-related macular degeneration","volume":"232","author":"Khanani","year":"2021","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.xops.2022.100192_bib24","doi-asserted-by":"crossref","first-page":"4563","DOI":"10.1167\/iovs.04-0598","article-title":"FAS-mediated apoptosis and its relation to intrinsic pathway activation in an experimental model of retinal detachment","volume":"45","author":"Zacks","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2022.100192_bib25","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1001\/archopht.125.10.1389","article-title":"Role of the Fas-signaling pathway in photoreceptor neuroprotection","volume":"125","author":"Zacks","year":"2007","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.xops.2022.100192_bib26","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1167\/iovs.09-4439","article-title":"Inhibition of retinal detachment-induced apoptosis in photoreceptors by a small peptide inhibitor of the fas receptor","volume":"51","author":"Besirli","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2022.100192_bib27","doi-asserted-by":"crossref","first-page":"21695","DOI":"10.1073\/pnas.1009179107","article-title":"Receptor interacting protein kinases mediate retinal detachment-induced photoreceptor necrosis and compensate for inhibition of apoptosis","volume":"107","author":"Trichonas","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.xops.2022.100192_bib28","doi-asserted-by":"crossref","first-page":"497","DOI":"10.18632\/oncotarget.286","article-title":"RIP kinase-mediated necrosis as an alternative mechanisms of photoreceptor death","volume":"2","author":"Murakami","year":"2011","journal-title":"Oncotarget"},{"key":"10.1016\/j.xops.2022.100192_bib29","doi-asserted-by":"crossref","first-page":"14598","DOI":"10.1073\/pnas.1206937109","article-title":"Receptor interacting protein kinase mediates necrotic cone but not rod cell death in a mouse model of inherited degeneration","volume":"109","author":"Murakami","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.xops.2022.100192_bib30","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/cdd.2013.109","article-title":"Programmed necrosis, not apoptosis, is a key mediator of cell loss and DAMP-mediated inflammation in dsRNA-induced retinal degeneration","volume":"21","author":"Murakami","year":"2014","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.xops.2022.100192_bib31","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2015.334","article-title":"Membrane-bound and soluble Fas ligands have opposite functions in photoreceptor cell death following separation from the retinal pigment epithelium","volume":"6","author":"Matsumoto","year":"2015","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.xops.2022.100192_bib32","doi-asserted-by":"crossref","first-page":"e1269","DOI":"10.1038\/cddis.2014.218","article-title":"Mammalian STE20-like kinase 2, not kinase 1, mediates photoreceptor cell death during retinal detachment","volume":"5","author":"Matsumoto","year":"2014","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.xops.2022.100192_bib33","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1167\/iovs.14-15877","article-title":"Intravitreal sirolimus for the treatment of geographic atrophy: results of a phase I\/II clinical trial","volume":"56","author":"Petrou","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2022.100192_bib34","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1167\/iovs.13-11650","article-title":"Treatment of geographic atrophy with subconjunctival sirolimus: results of a Phase I\/II Clinical Trial","volume":"54","author":"Wong","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2022.100192_bib35","doi-asserted-by":"crossref","first-page":"6241","DOI":"10.1073\/pnas.1018987108","article-title":"Ciliary neurotrophic factor delivered by encapsulated cell intraocular implants for treatment of geographic atrophy in age-related macular degeneration","volume":"108","author":"Zhang","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.xops.2022.100192_bib36","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ajo.2016.07.013","article-title":"Long-term follow-up of patients with retinitis pigmentosa receiving intraocular ciliary neurotrophic factor implants","volume":"170","author":"Birch","year":"2016","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.xops.2022.100192_bib37","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1001\/archopht.120.6.797","article-title":"Up-regulation of brain-derived neurotrophic factor expression by brimonidine in rat retinal ganglion cells","volume":"120","author":"Gao","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.xops.2022.100192_bib38","first-page":"2849","article-title":"Neuroprotection of retinal ganglion cells by brimonidine in rats with laser-induced chronic ocular hypertension","volume":"42","author":"WoldeMussie","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2022.100192_bib39","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.ajo.2010.09.026","article-title":"A\u00a0randomized trial of brimonidine versus timolol in preserving visual function: results from the Low-Pressure Glaucoma Treatment Study","volume":"151","author":"Krupin","year":"2011","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.xops.2022.100192_bib40","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/IAE.0000000000002789","article-title":"Phase 2 Study of the Safety and Efficacy of Brimonidine Drug Delivery System (BRIMO DDS) Generation 1 in patients with geographic atrophy secondary to age-related macular degeneration","volume":"41","author":"Kuppermann","year":"2021","journal-title":"Retina"},{"key":"10.1016\/j.xops.2022.100192_bib41","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.ajo.2015.08.024","article-title":"Randomized trial to evaluate tandospirone in geographic atrophy secondary to age-related macular degeneration: the GATE Study","volume":"160","author":"Jaffe","year":"2015","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.xops.2022.100192_bib42","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/j.ophtha.2012.04.030","article-title":"Sustained delivery fluocinolone acetonide vitreous inserts provide benefit for at least 3 years in patients with diabetic macular edema","volume":"119","author":"Campochiaro","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2022.100192_bib43","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ajo.2017.04.006","article-title":"Experience with a subretinal cell-based therapy in patients with geographic atrophy secondary to age-related macular degeneration","volume":"179","author":"Ho","year":"2017","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.xops.2022.100192_bib44","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.oret.2019.11.011","article-title":"Safety and efficacy of subretinally administered palucorcel for geographic atrophy of age-related macular degeneration","volume":"4","author":"Heier","year":"2020","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.xops.2022.100192_bib45","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1001\/jamaophthalmol.2013.5799","article-title":"Geographic atrophy: a histopathological assessment","volume":"132","author":"Bird","year":"2014","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.xops.2022.100192_bib46","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/00006982-199902000-00010","article-title":"Characterization of peroxidized lipids in Bruch\u2019s membrane","volume":"19","author":"Spaide","year":"1999","journal-title":"Retina"},{"key":"10.1016\/j.xops.2022.100192_bib47","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1001\/archopht.122.4.598","article-title":"Current concepts in the pathogenesis of age-related macular degeneration","volume":"122","author":"Zarbin","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.xops.2022.100192_bib48","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1167\/iovs.03-1114","article-title":"Expression of cone-photoreceptor-specific antigens in a cell line derived from retinal tumors in transgenic mice","volume":"45","author":"Tan","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2022.100192_bib49","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1006\/exer.1996.0020","article-title":"ARPE-19, a human retinal pigment epithelial cell line with differentiated properties","volume":"62","author":"Dunn","year":"1996","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.xops.2022.100192_bib50","first-page":"567","article-title":"Patient-specific iPSC-derived RPE for modeling of retinal diseases","volume":"4","author":"Nguyen","year":"2015","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.xops.2022.100192_bib51","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.mam.2012.06.003","article-title":"Animal models of age related macular degeneration","volume":"33","author":"Pennesi","year":"2012","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.xops.2022.100192_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2020.108404","article-title":"Progress in developing rodent models of age-related macular degeneration (AMD)","volume":"203","author":"Soundara Pandi","year":"2021","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.xops.2022.100192_bib53","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1167\/iovs.12-9662","article-title":"The Rd8 mutation of the Crb1 gene is present in vendor lines of C57BL\/6N mice and embryonic stem cells, and confounds ocular induced mutant phenotypes","volume":"53","author":"Mattapallil","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2022.100192_bib54","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.exer.2012.11.015","article-title":"Ccl2, Cx3cr1 and Ccl2\/Cx3cr1 chemokine deficiencies are not sufficient to cause age-related retinal degeneration","volume":"107","author":"Luhmann","year":"2013","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.xops.2022.100192_bib55","doi-asserted-by":"crossref","first-page":"E3040","DOI":"10.1073\/pnas.1424391112","article-title":"Regulation of age-related macular degeneration-like pathology by complement factor H","volume":"112","author":"Toomey","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.xops.2022.100192_bib56","doi-asserted-by":"crossref","first-page":"3703","DOI":"10.1073\/pnas.1814014116","article-title":"Human complement factor H Y402H polymorphism causes an age-related macular degeneration phenotype and lipoprotein dysregulation in mice","volume":"116","author":"Landowski","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.xops.2022.100192_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2022.100118","article-title":"Systemic complement activation profiles in nonexudative age-related macular degeneration: a systematic review","volume":"2","author":"Lin","year":"2022","journal-title":"Ophthalmol Sci"},{"key":"10.1016\/j.xops.2022.100192_bib58","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.120824","article-title":"Impaired monocyte cholesterol clearance initiates age-related retinal degeneration and vision loss","volume":"3","author":"Ban","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.xops.2022.100192_bib59","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1194\/jlr.M084442","article-title":"Disrupted cholesterol metabolism promotes age-related photoreceptor neurodegeneration","volume":"59","author":"Ban","year":"2018","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.xops.2022.100192_bib60","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.45100","article-title":"Impaired ABCA1\/ABCG1-mediated lipid efflux in the mouse retinal pigment epithelium (RPE) leads to retinal degeneration","volume":"8","author":"Storti","year":"2019","journal-title":"Elife"},{"key":"10.1016\/j.xops.2022.100192_bib61","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1001\/archopht.123.11.1570","article-title":"A\u00a0simplified severity scale for age-related macular degeneration: AREDS Report No. 18","volume":"123","author":"Ferris","year":"2005","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.xops.2022.100192_bib62","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.ophtha.2018.09.045","article-title":"Increased high-density lipoprotein levels associated with age-related macular degeneration: evidence from the EYE-RISK and European Eye Epidemiology Consortia","volume":"126","author":"Colijn","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2022.100192_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2021.100951","article-title":"Retinal applications of swept source optical coherence tomography (OCT) and optical coherence tomography angiography (OCTA)","volume":"84","author":"La\u00edns","year":"2021","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.xops.2022.100192_bib64","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s10038-020-0750-x","article-title":"Genome-wide meta-analysis identifies novel loci associated with age-related macular degeneration","volume":"65","author":"Han","year":"2020","journal-title":"J\u00a0Hum Genet"},{"key":"10.1016\/j.xops.2022.100192_bib65","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.ophtha.2020.11.024","article-title":"Genetic risk, lifestyle, and age-related macular degeneration in Europe: The EYE-RISK Consortium","volume":"128","author":"Colijn","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2022.100192_bib66","doi-asserted-by":"crossref","first-page":"e669","DOI":"10.1111\/aos.14970","article-title":"Genetic associations of anti-vascular endothelial growth factor therapy response in age-related macular degeneration: a systematic review and meta-analysis","volume":"100","author":"Wang","year":"2022","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.xops.2022.100192_bib67","article-title":"The effect of systemic levels of TNF-alpha and complement pathway activity on outcomes of VEGF inhibition in neovascular AMD","author":"Khan","year":"2021","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.xops.2022.100192_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2021.100017","article-title":"Genomic-metabolomic associations support the role of LIPC and glycerophospholipids in age-related macular degeneration","volume":"1","author":"Lains","year":"2021","journal-title":"Ophthalmol Sci"},{"key":"10.1016\/j.xops.2022.100192_bib69","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/s41433-021-01780-y","article-title":"Dyslipidemia in age-related macular degeneration","volume":"36","author":"Lin","year":"2022","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.xops.2022.100192_bib70","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.preteyeres.2016.04.003","article-title":"Risk factors and biomarkers of age-related macular degeneration","volume":"54","author":"Lambert","year":"2016","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.xops.2022.100192_bib71","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s41392-019-0063-8","article-title":"History and progress of hypotheses and clinical trials for Alzheimer\u2019s disease","volume":"4","author":"Liu","year":"2019","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.xops.2022.100192_bib72","doi-asserted-by":"crossref","first-page":"197","DOI":"10.14283\/jpad.2022.30","article-title":"Two randomized phase 3 studies of aducanumab in early Alzheimer\u2019s disease","volume":"9","author":"Budd Haeberlein","year":"2022","journal-title":"J\u00a0Prev Alzheimers Dis"},{"key":"10.1016\/j.xops.2022.100192_bib73","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.3233\/JAD-220262","article-title":"Making the case for accelerated withdrawal of aducanumab","volume":"87","author":"Whitehouse","year":"2022","journal-title":"J\u00a0Alzheimers Dis"},{"key":"10.1016\/j.xops.2022.100192_bib74","doi-asserted-by":"crossref","first-page":"999","DOI":"10.3233\/JAD-220264","article-title":"Making the case for the accelerated withdrawal of aducanumab","volume":"87","author":"Whitehouse","year":"2022","journal-title":"J\u00a0Alzheimers Dis"},{"key":"10.1016\/j.xops.2022.100192_bib75","first-page":"CD006537","article-title":"Laser treatment of drusen to prevent progression to advanced age-related macular degeneration","author":"Virgili","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.xops.2022.100192_bib76","unstructured":"Kouli A, Torsney KM, Kuan W-L. Parkinson\u2019s disease: etiology, neuropathology, and pathogenesis. In: Stoker TB, Greenland JC, eds. Parkinson\u2019s Disease: Pathogenesis and Clinical Aspects. Brisbane, AU: Codon Publications; 2018. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK536722\/. Accessed June 5,\u00a02022."},{"key":"10.1016\/j.xops.2022.100192_bib77","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1001\/archneur.62.3.353","article-title":"Molecular pathogenesis of Parkinson disease","volume":"62","author":"Eriksen","year":"2005","journal-title":"Arch Neurol"},{"key":"10.1016\/j.xops.2022.100192_bib78","unstructured":"Zahoor I, Shafi A, Haq E. Pharmacological treatment of Parkinson\u2019s disease. In: Stoker TB, Greenland JC, eds. Parkinson\u2019s Disease: Pathogenesis and Clinical Aspects. Brisbane, AU: Codon Publications; 2018. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK536726\/. Accessed June 5,\u00a02022."},{"key":"10.1016\/j.xops.2022.100192_bib79","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.neuron.2019.11.006","article-title":"Single-cell profiles of retinal ganglion cells differing in resilience to injury reveal neuroprotective genes","volume":"104","author":"Tran","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.xops.2022.100192_bib80","doi-asserted-by":"crossref","first-page":"23705","DOI":"10.1073\/pnas.1908355116","article-title":"RIP1 kinase mediates angiogenesis by modulating macrophages in experimental neovascularization","volume":"116","author":"Ueta","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.xops.2022.100192_bib81","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2015.385","article-title":"Necrotic cone photoreceptor cell death in retinitis pigmentosa","volume":"6","author":"Murakami","year":"2015","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.xops.2022.100192_bib82","doi-asserted-by":"crossref","DOI":"10.1038\/cddiscovery.2015.58","article-title":"Necrotic enlargement of cone photoreceptor cells and the release of high-mobility group box-1 in retinitis pigmentosa","volume":"1","author":"Murakami","year":"2015","journal-title":"Cell Death Discov"},{"key":"10.1016\/j.xops.2022.100192_bib83","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.preteyeres.2013.08.001","article-title":"Photoreceptor cell death and rescue in retinal detachment and degenerations","volume":"37","author":"Murakami","year":"2013","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.xops.2022.100192_bib84","doi-asserted-by":"crossref","first-page":"17458","DOI":"10.1523\/JNEUROSCI.1380-13.2013","article-title":"Receptor interacting protein kinase-mediated necrosis contributes to cone and rod photoreceptor degeneration in the retina lacking interphotoreceptor retinoid-binding protein","volume":"33","author":"Sato","year":"2013","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.xops.2022.100192_bib85","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2015.73","article-title":"Macrophage- and RIP3-dependent inflammasome activation exacerbates retinal detachment-induced photoreceptor cell death","volume":"6","author":"Kataoka","year":"2015","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.xops.2022.100192_bib86","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0040065","article-title":"Etanercept, a widely used inhibitor of tumor necrosis factor-\u03b1 (TNF-\u03b1), prevents retinal ganglion cell loss in a rat model of glaucoma","volume":"7","author":"Roh","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.xops.2022.100192_bib87","doi-asserted-by":"crossref","first-page":"3825","DOI":"10.1167\/iovs.10-6797","article-title":"Edaravone, an ROS scavenger, ameliorates photoreceptor cell death after experimental retinal detachment","volume":"52","author":"Roh","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2022.100192_bib88","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.bbrc.2019.10.138","article-title":"Lysosome-associated membrane protein-2 deficiency increases the risk of reactive oxygen species-induced ferroptosis in retinal pigment epithelial cells","volume":"521","author":"Lee","year":"2020","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.xops.2022.100192_bib89","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13490","article-title":"Intraocular iron injection induces oxidative stress followed by elements of geographic atrophy and sympathetic ophthalmia","volume":"20","author":"Liu","year":"2021","journal-title":"Aging Cell"},{"key":"10.1016\/j.xops.2022.100192_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101469","article-title":"Ferrous but not ferric iron sulfate kills photoreceptors and induces photoreceptor-dependent RPE autofluorescence","volume":"34","author":"Shu","year":"2020","journal-title":"Redox Biol"},{"key":"10.1016\/j.xops.2022.100192_bib91","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.preteyeres.2007.07.004","article-title":"Iron homeostasis and toxicity in retinal degeneration","volume":"26","author":"He","year":"2007","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.xops.2022.100192_bib92","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1167\/iovs.08-2545","article-title":"Iron chelation protects the retinal pigment epithelial cell line ARPE-19 against cell death triggered by diverse stimuli","volume":"50","author":"Lukinova","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2022.100192_bib93","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1167\/iovs.16-21392","article-title":"Protective effect of Met12, a small peptide inhibitor of Fas, on the retinal pigment epithelium and photoreceptor after sodium iodate injury","volume":"58","author":"Xiao","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2022.100192_bib94","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s12974-019-1576-3","article-title":"A\u00a0small peptide antagonist of the Fas receptor inhibits neuroinflammation and prevents axon degeneration and retinal ganglion cell death in an inducible mouse model of glaucoma","volume":"16","author":"Krishnan","year":"2019","journal-title":"J\u00a0Neuroinflammation"},{"key":"10.1016\/j.xops.2022.100192_bib95","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0244307","article-title":"Acadesine suppresses TNF-\u03b1 induced complement component 3 (C3), in retinal pigment epithelial (RPE) cells","volume":"15","author":"Efstathiou","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.xops.2022.100192_bib96","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-17744-w","article-title":"AICAR suppresses TNF-\u03b1-induced complement factor B in RPE cells","volume":"7","author":"Chung","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.xops.2022.100192_bib97","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.3390\/biom11081239","article-title":"Targeting the NLRP3 inflammasome in glaucoma","volume":"11","author":"Coyle","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.xops.2022.100192_bib98","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/nm.2717","article-title":"NLRP3 has a protective role in age-related macular degeneration through the induction of IL-18 by drusen components","volume":"18","author":"Doyle","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.xops.2022.100192_bib99","first-page":"172","article-title":"NLRP3 inflammasome and pathobiology in AMD","volume":"4","author":"Celkova","year":"2015","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.xops.2022.100192_bib100","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.exer.2019.01.018","article-title":"NLRP3 inflammasome in NMDA-induced retinal excitotoxicity","volume":"181","author":"Tsoka","year":"2019","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.xops.2022.100192_bib101","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/s41598-017-17634-1","article-title":"Issues with the specificity of immunological reagents for NLRP3: implications for age-related macular degeneration","volume":"8","author":"Kosmidou","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.xops.2022.100192_bib102","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1016\/j.bbamcr.2015.08.012","article-title":"Mitochondrial DNA has a pro-inflammatory role in AMD","volume":"1853","author":"Dib","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.xops.2022.100192_bib103","doi-asserted-by":"crossref","first-page":"539","DOI":"10.4049\/jimmunol.1800982","article-title":"Microglia regulate neuroglia remodeling in various ocular and retinal injuries","volume":"202","author":"Paschalis","year":"2019","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.xops.2022.100192_bib104","doi-asserted-by":"crossref","first-page":"E11359","DOI":"10.1073\/pnas.1807123115","article-title":"Permanent neuroglial remodeling of the retina following infiltration of CSF1R inhibition-resistant peripheral monocytes","volume":"115","author":"Paschalis","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.xops.2022.100192_bib105","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.ajpath.2018.03.005","article-title":"The role of microglia and peripheral monocytes in retinal damage after corneal chemical injury","volume":"188","author":"Paschalis","year":"2018","journal-title":"Am J Pathol"},{"key":"10.1016\/j.xops.2022.100192_bib106","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.ajpath.2017.02.005","article-title":"Mechanisms of retinal damage after ocular alkali burns","volume":"187","author":"Paschalis","year":"2017","journal-title":"Am J Pathol"},{"key":"10.1016\/j.xops.2022.100192_bib107","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1056\/NEJMcp1915826","article-title":"HIV infection - screening, diagnosis, and treatment","volume":"384","author":"Saag","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.xops.2022.100192_bib108","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1056\/NEJMra1413919","article-title":"Treatment of tuberculosis","volume":"373","author":"Horsburgh","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.xops.2022.100192_bib109","doi-asserted-by":"crossref","first-page":"38022","DOI":"10.18632\/oncotarget.16723","article-title":"Combination therapy in combating cancer","volume":"8","author":"Bayat Mokhtari","year":"2017","journal-title":"Oncotarget"}],"container-title":["Ophthalmology Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666914522000811?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666914522000811?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T06:22:06Z","timestamp":1763014926000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666914522000811"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":109,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S2666914522000811"],"URL":"https:\/\/doi.org\/10.1016\/j.xops.2022.100192","relation":{},"ISSN":["2666-9145"],"issn-type":[{"value":"2666-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuroprotection for Age-Related Macular Degeneration","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xops.2022.100192","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 by the American Academy of Ophthalmology.","name":"copyright","label":"Copyright"}],"article-number":"100192"}}